American Capital Management Has Lowered By $899,822 Its Resmed (RMD) Holding; Magellan Midstream Partners LP (MMP) Shorts Raised By 7.79%

December 9, 2017 - By Winifred Garcia

American Capital Management Inc decreased Resmed (RMD) stake by 1.76% reported in 2017Q2 SEC filing. American Capital Management Inc sold 11,686 shares as Resmed (RMD)’s stock declined 5.35%. The American Capital Management Inc holds 653,334 shares with $50.88 million value, down from 665,020 last quarter. Resmed now has $12.26B valuation. The stock increased 0.70% or $0.6 during the last trading session, reaching $86.37. About 550,082 shares traded. ResMed Inc. (NYSE:RMD) has risen 20.34% since December 9, 2016 and is uptrending. It has outperformed by 3.64% the S&P500.

Magellan Midstream Partners LP (NYSE:MMP) had an increase of 7.79% in short interest. MMP’s SI was 4.81M shares in December as released by FINRA. Its up 7.79% from 4.46M shares previously. With 813,500 avg volume, 6 days are for Magellan Midstream Partners LP (NYSE:MMP)’s short sellers to cover MMP’s short positions. The SI to Magellan Midstream Partners LP’s float is 2.11%. The stock increased 0.18% or $0.12 during the last trading session, reaching $67.1. About 631,752 shares traded. Magellan Midstream Partners, L.P. (NYSE:MMP) has risen 3.55% since December 9, 2016 and is uptrending. It has underperformed by 13.15% the S&P500.

Investors sentiment increased to 0.9 in Q2 2017. Its up 0.07, from 0.83 in 2017Q1. It increased, as 38 investors sold Magellan Midstream Partners, L.P. shares while 153 reduced holdings. 37 funds opened positions while 134 raised stakes. 131.72 million shares or 0.48% less from 132.35 million shares in 2017Q1 were reported. Assetmark Incorporated has invested 0% in Magellan Midstream Partners, L.P. (NYSE:MMP). Independent Port Consultants owns 0.06% invested in Magellan Midstream Partners, L.P. (NYSE:MMP) for 1,968 shares. Renaissance Technologies Ltd Liability Corp invested in 871,016 shares or 0.08% of the stock. Mariner Grp Ltd Liability Corp, New York-based fund reported 193,740 shares. Provise Mngmt Group Limited Liability Company stated it has 0.37% of its portfolio in Magellan Midstream Partners, L.P. (NYSE:MMP). Arrow Corporation invested 0% of its portfolio in Magellan Midstream Partners, L.P. (NYSE:MMP). Salient Trust Lta holds 0.08% or 9,568 shares in its portfolio. 11,699 were reported by Brown Brothers Harriman &. Jefferies Gru Ltd Limited Liability Company invested 0% of its portfolio in Magellan Midstream Partners, L.P. (NYSE:MMP). 8,985 are held by Aperio Ltd Liability Com. Nbw Capital Lc reported 0.06% stake. The Texas-based Hourglass Capital Lc has invested 0.16% in Magellan Midstream Partners, L.P. (NYSE:MMP). Bank Of The West reported 0.08% in Magellan Midstream Partners, L.P. (NYSE:MMP). Granite Inv Partners Ltd Limited Liability Company has 6,300 shares. 81,418 are held by Pinnacle Holdg Llc.

Magellan Midstream Partners, L.P. engages in the transportation, storage, and distribution of refined petroleum products and crude oil in the United States. The company has market cap of $15.30 billion. The firm operates through Refined Products, Crude Oil, and Marine Storage divisions. It has a 18.14 P/E ratio. It operates refined products pipeline that transports gasoline, distillates, aviation fuels, and liquefied petroleum gases for independent and integrated oil companies, wholesalers, retailers, traders, railroads, airlines, and regional farm cooperatives; and provides services, including terminalling, ethanol and biodiesel unloading and loading, additive injection, custom blending, laboratory testing, and data services.

Among 20 analysts covering Magellan Midstream Partners L.P. (NYSE:MMP), 9 have Buy rating, 2 Sell and 9 Hold. Therefore 45% are positive. Magellan Midstream Partners L.P. had 51 analyst reports since August 7, 2015 according to SRatingsIntel. Argus Research maintained Magellan Midstream Partners, L.P. (NYSE:MMP) rating on Monday, August 10. Argus Research has “Buy” rating and $85.0 target. Credit Suisse upgraded the shares of MMP in report on Friday, August 7 to “Neutral” rating. The firm has “Underweight” rating by Morgan Stanley given on Thursday, August 18. The firm has “Outperform” rating given on Thursday, January 12 by Raymond James. Wunderlich downgraded Magellan Midstream Partners, L.P. (NYSE:MMP) on Monday, April 4 to “Hold” rating. The firm earned “Neutral” rating on Friday, September 30 by Mizuho. Stifel Nicolaus maintained the shares of MMP in report on Monday, July 17 with “Hold” rating. The rating was upgraded by UBS to “Buy” on Tuesday, July 18. RBC Capital Markets maintained it with “Hold” rating and $80.0 target in Sunday, October 1 report. As per Saturday, August 8, the company rating was maintained by Raymond James.

Among 14 analysts covering ResMed Inc (NYSE:RMD), 4 have Buy rating, 4 Sell and 6 Hold. Therefore 29% are positive. ResMed Inc had 41 analyst reports since August 3, 2015 according to SRatingsIntel. The stock of ResMed Inc. (NYSE:RMD) has “Underweight” rating given on Thursday, April 7 by Barclays Capital. The rating was upgraded by Macquarie Research on Thursday, April 28 to “Neutral”. Credit Suisse downgraded the stock to “Neutral” rating in Wednesday, August 2 report. Piper Jaffray maintained the stock with “Hold” rating in Wednesday, August 2 report. On Wednesday, April 27 the stock rating was downgraded by Piper Jaffray to “Neutral”. The stock of ResMed Inc. (NYSE:RMD) has “Overweight” rating given on Tuesday, January 24 by JP Morgan. Needham maintained ResMed Inc. (NYSE:RMD) on Friday, September 8 with “Sell” rating. On Friday, September 25 the stock rating was upgraded by Goldman Sachs to “Buy”. The company was maintained on Friday, September 22 by Needham. The stock has “Underperform” rating by Jefferies on Tuesday, August 23.

Analysts await ResMed Inc. (NYSE:RMD) to report earnings on January, 22. They expect $0.76 earnings per share, up 4.11% or $0.03 from last year’s $0.73 per share. RMD’s profit will be $107.84M for 28.41 P/E if the $0.76 EPS becomes a reality. After $0.66 actual earnings per share reported by ResMed Inc. for the previous quarter, Wall Street now forecasts 15.15% EPS growth.

Since June 14, 2017, it had 0 buys, and 1 insider sale for $1.85 million activity. Another trade for 24,390 shares valued at $1.85 million was made by PACE GARY W on Wednesday, June 14.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: